| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.006 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.007 |